This is the old version of SRDR. The next, SRDRplus is available! Registration of your SRDRPlus account is free and approval is automatic. Click Here to register an SRDRPlus account.

Advanced Search

Study Preview

Study Title and Description

A prospective, randomized, controlled trial of autologous platelet-rich plasma gel for the treatment of diabetic foot ulcers.

Key Questions Addressed
1 KQ 1. What are the benefits and harms of treatment strategies including PRP alone with or without other wound care treatments compared with other wound care treatments in patients with diabetic, venous and pressure chronic wounds, for patient oriented outcomes such as at least the following: completely closed/healed wounds (skin closure with complete re-epithelialization without drainage or dressing requirements), time to complete wound closure, wound reoccurrence, risk of developing wound infection, amputation, hospitalization (frequency and duration), return to baseline activities and function, reduction of wound size, pain, opioid medication use, exudate and odor, quality of life and adverse effects? KQ 1.a. Describe the risk of bias in the studies examined by chronic wound type and study design. KQ 1.b What are the differences in formulation techniques and components between these preparations? What are the differences in application techniques, frequency of application and “dosage” (amounts applied)? KQ 1.c What are the study characteristics (such as those listed below) in each included investigation for each chronic wound type treated by PRP? i. Comparator (if standard care, describe in detail). ii. Study inclusion/exclusion criteria and patient characteristics of enrollees, including at least age, gender, and general health (e.g., status of HbA1c, diabetes, peripheral vascular disease, obesity, smoking, renal), wound characteristics, and prior and concurrent wound treatments. iii. Wound characteristics of enrollees including at least wound type, wound size/depth/duration/severity, vascular status, infection status and whether there were inter- and intra-rater checks of wound measurements. iv. Basic study design and conduct information including at least method of patient enrollment, care setting, and use of run-in period. v. Definition of wound characteristics: definition of “failure to heal”, and definition of a successfully healed wound (re-epithelialization). vi. Method of applying skin PRP including provider, frequency of application, definition of standard of care, and handling of infections. vii. Measurement and assessment methods including method of assessment(s); frequency and time points for assessment(s) (including long term assessments for durability of heal); and blinding of assessors. KQ 1.d Based on the included studies, what are the patient characteristics commonly considered for the initiation and continuation/discontinuation of PRP in patients with chronic wounds?
  • Comments Comments (
    ) |

Primary Publication Information
  • Comments Comments (
    ) |
Title A prospective, randomized, controlled trial of autologous platelet-rich plasma gel for the treatment of diabetic foot ulcers.
Author Driver VR., Hanft J., Fylling CP., Beriou JM.
Country Cytomedix, Inc., 416 Hungerford Drive, Rockville, MD 20850, USA.
Year 2006
Numbers Pubmed ID: 16799184

Secondary Publication Information
There are currently no secondary publications defined for this study.

Extraction Form: Platelet-Rich Plasma for Wound Care
Design Details
Question... Follow Up Answer Follow-up Answer

Results & Comparisons

No Results found.